Moderna Inc (MRNA) stock is higher by 281.84% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives MRNA stock a score of 77 out of a possible 100.
That rank is primarily influenced by a long-term technical score of 91. MRNA's rank also includes a short-term technical score of 88. The fundamental score for MRNA is 52. In addition to the average rating from Wall Street analysts, MRNA stock has a mean target price of 83.888. This means analysts expect the stock to add 43.50% over the next 12 months.
What's Happening with MRNA Stock Today
Moderna Inc (MRNA) stock has fallen -5.08% while the S&P 500 is higher by 0.69% as of 3:32 PM on Thursday, Jul 2. MRNA is lower by -$3.13 from the previous closing price of $61.59 on volume of 23,530,937 shares. Over the past year the S&P 500 has gained 4.73% while MRNA is higher by 281.84%. MRNA lost -$1.50 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Moderna Inc (MRNA) Stock.
